These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12520325)

  • 21. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
    Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
    Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
    Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Wilms tumor.
    Ruteshouser EC; Huff V
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel zinc finger mutation in a patient with Denys-Drash syndrome.
    Baird PN; Cowell JK
    Hum Mol Genet; 1993 Dec; 2(12):2193-4. PubMed ID: 8111391
    [No Abstract]   [Full Text] [Related]  

  • 25. Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.
    Lugtenberg RT; Cransberg K; Loos WJ; Wagner A; Alders M; van den Heuvel-Eibrink MM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1039-44. PubMed ID: 18273617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The two-hit model for Wilms' tumor: where are we 30 years later?
    Strong LC
    Genes Chromosomes Cancer; 2003 Dec; 38(4):294-9. PubMed ID: 14566846
    [No Abstract]   [Full Text] [Related]  

  • 27. [Molecular genetics of Wilm's tumor].
    Kaplinsky C; Rechavi G
    Harefuah; 1997 May; 132(10):706-10. PubMed ID: 9223799
    [No Abstract]   [Full Text] [Related]  

  • 28. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
    Udtha M; Lee SJ; Alam R; Coombes K; Huff V
    Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
    Wagner KJ; Roberts SG
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC; Hendrickson BW; Colella S; Krahe R; Pinto L; Huff V
    Genes Chromosomes Cancer; 2005 Jun; 43(2):172-80. PubMed ID: 15761866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.
    Ohshima J; Haruta M; Arai Y; Kasai F; Fujiwara Y; Ariga T; Okita H; Fukuzawa M; Hata J; Horie H; Kaneko Y
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1037-50. PubMed ID: 19760604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin-like growth factor II in overgrowth and Wilms' tumorigenesis.
    Algar EM; St Heaps L; Darmanian A; Dagar V; Prawitt D; Peters GB; Collins F
    Cancer Res; 2007 Mar; 67(5):2360-5. PubMed ID: 17325026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephroblastic neoplasms.
    Khoury JD
    Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutional and acquired rearrangements of chromosome 7 in Wilms tumor.
    Rivera H
    Cancer Genet Cytogenet; 1995 May; 81(1):97-8. PubMed ID: 7773968
    [No Abstract]   [Full Text] [Related]  

  • 39. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.
    Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M
    Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of genetic disorders in the etiology of nephroblastoma].
    Sporny S
    Wiad Lek; 1981 May; 34(10):835-8. PubMed ID: 6270915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.